Instead of requiring personalized gene edits for each patient, the new approach could create a standardized method to use for ...

CRISPR gene-editing technology lets scientists make precise changes to an organism’s DNA. Invented in 2012 by Jennifer Doudna and Emmanuelle Charpentier, biochemists who went on to win the Nobel prize ...

Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its ...

Using CRISPR gene editing technology, researchers from Jiangnan University in China took a fungus that is already used as a ...

As tech titans back startups looking to create genetically modified babies, Claudia Cockerell asks: is it about stopping ...

The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by ...

YolTech Therapeutics, a clinical-stage biotechnology company developing next-generation in vivo gene editing therapies, today announced that the U.S. Food and Drug Administration (FDA) has cleared the ...

Explore CRISPR technology explained, gene editing science, DNA modification, and genetic engineering ethics—discover how ...

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...

Broken String Biosciences ("Broken String"), a leader in advancing gene editing safety, today announced the appointment of ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the best gene-editing stocks to buy according to hedge funds.

An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.